Click here to download a full list of RICE Publications 

2019 - Original Papers

Clare L, Kudlicka A, Oyebode JR, Jones RW, Bayer A, Leroi I, Kopelman M, James IA, Culverwell A, Pool J, Brand A, Henderson C, Hoare Z, Knapp M, Woods B.
Individual goal-oriented cognitive rehabilitation to improve everyday functioning for people with early-stage dementia: A multi-centre randomised controlled trial (the GREAT trial). Int J Geriatr Psychiatry. 2019 Feb 6. [Epub ahead of print]

Clare L, Kudlicka A, Oyebode JR, Jones RW, Bayer A, Leroi I, Kopelman M, James IA, Culverwell A, Pool J, Brand A, Henderson C, Hoare Z, Knapp M, Morgan-Trimmer S, Burns A, Corbett A, Whitaker R, Woods B. 
Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT. Health Technol Assess. 2019 Mar;23(10):1-242. 

Clare L, Wu YT, Jones IR, Victor CR, Nelis SM, Martyr A, Quinn C, LitherlandR, Pickett JA, Hindle JV, Jones RW, Knapp M, Kopelman MD, Morris RG, Rusted JM,Thom JM, Lamont RA, Henderson C, Rippon I, Hillman A, Matthews FE; IDEAL StudyTeam. 
A Comprehensive Model of Factors Associated With Subjective Perceptions of "Living Well" With Dementia: Findings From the IDEAL Study. Alzheimer Dis AssocDisord. 2019 Jan-Mar;33(1):36-41. 

Clare L, Wu YT, Quinn C, Jones IR, Victor CR, Nelis SM, Martyr A, LitherlandR, Pickett JA, Hindle JV, Jones RW, Knapp M, Kopelman MD, Morris RG, Rusted JM,Thom JM, Lamont RA, Henderson C, Rippon I, Hillman A, Matthews FE; IDEAL StudyTeam. 
A Comprehensive Model of Factors Associated With Capability to "Live Well" for Family Caregivers of People Living With Mild-to-Moderate Dementia: Findings from the IDEAL Study. Alzheimer Dis Assoc Disord. 2019 Jan-Mar;33(1):29-35. 

Henderson C, Knapp M, Nelis SM, Quinn C, Martyr A, Wu YT, Jones IR, Victor CR, Pickett JA, Hindle JV, Jones RW, Kopelman MD, Matthews FE, Morris RG, Rusted JM, Thom JM, Clare L; IDEAL Programme Team.
Use and costs of services and unpaid care for people with mild-to-moderate dementia: Baseline results from the IDEAL cohort study. Alzheimers Dement (N Y). 2019 Oct 31;5:685-696. 

Lamont RA, Nelis SM, Quinn C, Martyr A, Rippon I, Kopelman MD, Hindle JV, Jones RW, Litherland R, Clare L. 
Psychological predictors of 'living well' with dementia: findings from the IDEAL study. Aging Ment Health. 2019 Mar 5:1-9. [Epub ahead of print]  

Lampshire Z, Tingley D, Jarvis A, Wernham C, Hughes JC, Welsh TJ.
Fracture risk is under-recognised and under-treated in memory clinic attendees. Maturitas. 2019 May; 123:37-39. Epub 2019 Feb 12.

Nelis SM, Wu YT, Matthews FE, Martyr A, Quinn C, Rippon I, Rusted J, Thom JM, Kopelman MD, Hindle JV, Jones RW, Clare L.
The impact of co-morbidity on the quality of life of people with dementia: findings from the IDEAL study. Age Ageing. 2019 May 1;48(3):361-367. 

Reed C, Belger M, Scott Andrews J, Tockhorn-Heidenreich A, Jones RW, Wimo A, Dodel R, Haro JM.
Factors associated with long-term impact on informal caregivers during Alzheimer's disease dementia progression: 36-month results from GERAS. Int Psychogeriatr. 2019 May 28:1-11. Epub ahead of print.

Vermunt L, Sikkes SAM, van den Hout A, Handels R, Bos I, van der Flier WM, Kern S, Ousset PJ, Maruff P, Skoog I, Verhey FRJ, Freund-Levi Y, Tsolaki M, Wallin u00c5K, Olde Rikkert M, Soininen H, Spiru L, Zetterberg H, Blennow K, Scheltens P, Muniz-Terrera G, Visser PJ; Alzheimer Disease Neuroimaging Initiative; AIBL Research Group; ICTUS/DSA study groups. (Jones RW - collaborator).
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype. Alzheimers Dement. 2019 Jul;15(7):888-898. Epub 2019 Jun 1.

Welsh TJ.
Multimorbidity in people living with dementia. Case Rep Womens Health. 2019 May 22;23. 2019.e00125. eCollection 2019 Jul

Welsh TJ
, Gordon AL, Gladman JRF. Treatment of Hypertension in People with Dementia: A Multicenter Prospective Observational Cohort Study. J Am Med Dir Assoc. 2019 May 17 [Epub ahead of print] 

2018 - Original Papers

Belger M, Haro JM, Reed C, Happich M, Argimon JM, Bruno G, Dodel R, Jones RW, Vellas B, Wimo A.
Determinants of time to institutionalisation and related healthcare and societal costs in a community-based cohort of patients with Alzheimer's disease dementia. Eur J Health Econ. 2018 Sep 3. [Epub ahead of print]

Hughes, JC.
Insight: The concept, the assessment and the label. BJPsych Advances, 1-2.

Hughes JC.
Chaining, culture and values: ethical issues in research in middle and low income countries. Br J Psychiatry. 2018 Jan;212(1):9-10. 

Hughes J, Crepaz-Keay D, Emmett C, & Fulford K. 
The Montgomery ruling, individual values and shared decision-making in psychiatry. BJPsych Advances 2018 24(2), 93-100.

Hughes JC, Volicer L, van der Steen JT.
Complexity and gaps: The high-hanging fruit of dementia and palliative care research. Palliat Med. 2018 Mar;32(3):591-593. 

Ismail S, Christopher G, Dodd E, Wildschut T, Sedikides C, Ingram TA, Jones RW, Noonan KA, Tingley D, Cheston R.
Psychological and Mnemonic Benefits of Nostalgia for People with Dementia. J Alzheimers Dis. 2018 Aug 20. [Epub ahead of print]

Lenox-Smith A, Reed C, Lebrec J, Belger M, Jones RW
Potential cost savings to be made by slowing cognitive decline in mild Alzheimer's disease dementia using a model derived from the UK GERAS observational study. BMC Geriatr. 2018 Feb 23;18(1):57. 

MacCormick FM, Emmett C, Paes P, Hughes JC.
Resuscitation decisions at the end of life: medical views and the juridification of practice.J Med Ethics. 2018 Jun;44(6):376-383. doi: 10.1136/medethics-2017-104608. Epub 2018 Mar 9.

Nelis SM, Wu YT, Matthews FE, Martyr A, Quinn C, Rippon I, Rusted J, Thom JM, Kopelman MD, Hindle JV, Jones RW, Clare L.
The impact of comorbidity on the quality of life of people with dementia: findings from the IDEAL study. Age Ageing. 2018 Nov 7 [Epub ahead of print]

Poole M, Bamford C, McLellan E, Lee RP, Exley C, Hughes JC, Harrison-Dening K, Robinson L
End-of-life care: A qualitative study comparing the views of people with dementia and family carers .Palliat Med. 2018 Mar;32(3):631-642.

Silarova B, Nelis SM, Ashworth RM, Ballard C, Bieu0144kiewicz M, Henderson C, Hillman A, Hindle JV, Hughes JC, Lamont RA, Litherland R, Jones IR, Jones RW, Knapp M, Kotting P, Martyr A, Matthews FE, Morris RG, Quinn C, Regan J, Rusted JM, van den Heuvel EA, Victor CR, Wu YT, Clare L.
Protocol for the IDEAL-2 longitudinal study: following the experiences of people with dementia and their primary carers to understand what contributes to living well with dementia and enhances active life. BMC Public Health. 2018 Oct 30;18(1):1214.

van der Wardt V, Burton JK, Conroy S, Welsh T, Logan P, Taggar J, Tanajewski L, Gladman J.
Withdrawal of antihypertensive therapy in people with dementia: feasibility study. Pilot Feasibility Stud. 2018 Jan 9;4:29.  

Welsh T, Masoli J.
Antihypertensive medications may reduce the risk of dementia in older African-Americans with hypertension. Evid Based Nurs. 2018 Aug 1. [Epub ahead of print] 

Welsh TJ, van der Wardt V, Ojo G, Gordon AL, Gladman JRF.
Anticholinergic Drug Burden Tools/Scales and Adverse Outcomes in Different Clinical Settings: A Systematic Review of Reviews. Drugs Aging. 2018 May 8 [Epub ahead of print] Review.

Wernham C, Jordan A, Hughes JC.
Assessing pain in dementia: tools or tacit knowledge (or both)? Br J Gen Pract. 2018 Apr;68(669):196-197.

Wu YT, Clare L, Hindle JV, Nelis SM, Martyr A, Matthews FE; (RW jones Collaborator -Improving the experience of Dementia and Enhancing Active Life study).
Dementia subtype and living well: results from the Improving the experience of Dementia and Enhancing Active Life (IDEAL) study. BMC Med. 2018 Sep 11;16(1):140. 

2017 - Original Papers

Aisen PS, Cummings J, Jack CR Jr, Morris JC, Sperling R, Fru00f6lich L, Jones RW, Dowsett SA, Matthews BR, Raskin J, Scheltens P, Dubois B.
On the path to 2025: understanding the Alzheimer's disease continuum. Alzheimers Res Ther. 2017 Aug 9;9(1):60. 

Gustavsson A, Green C, Jones RW, Fu00f6rstl H, Simsek D, de Reydet de Vulpillieres F, Luthman S, Adlard N, Bhattacharyya S, Wimo A.
Current issues and future research priorities for health economic modelling across the full continuum of Alzheimer's disease. Alzheimers Dement. 2017 Mar;13(3):312-32.

Guzmu00e1n A, Robinson L, Rochester L, James IA, Hughes JC.
A process evaluation of a Psychomotor Dance Therapy Intervention (DANCIN) for behavior change in dementia: attitudes and beliefs of participating residents and staff. Int Psychogeriatr. 2017 Feb;29(2):313-322. Epub 2016 Nov 7.

Hughes JC. 
Rational Suicide in the Elderly: Clinical, Ethical, and Sociocultural Aspects. Br J Psychiatry. 2017 Jul;211(1):55. 

Hughes JC.
Whole sight: clinical and research priorities in old age psychiatry. Lancet Psychiatry. 2017 Feb;4(2):94-95.

Hughes JC, Ingram TA, Jarvis A, Denton E, Lampshire Z, Wernham C.
Consent for the diagnosis of preclinical dementia states: A review. Maturitas. 2017 Apr; 98:30-34. Epub 2017 Jan 19.

Jones RW, u00b7 Lebrec J,u00b7 Kahle-Wrobleski K, u00b7 Dellu2019Agnello G, u00b7 Bruno G, u00b7 Vellas B, u00b7 Argimon J.M,u00b7 Dodel R,u00b7 Haro JM, u00b7 Wimo A,u00b7 Reed C.
Disease Progression in Mild Dementia due to Alzheimer Disease in an 18-Month Observational Study (GERAS): The Impact on Costs and Caregiver Outcomes. Dement Geriatr Cogn Disord Extra 2017;7:87-100. 

Lenox-Smith A, Reed C, Lebrec J, Belger M, Jones RW.
Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational study. BMC Geriatr. 2016 Nov 25;16(1):195.

Reed C, Barrett A, Lebrec J, Dodel R, Jones RW, Vellas B, Wimo A, Argimon JM, Bruno G, Haro JM.How useful is the EQ-5D in assessing the impact of caring for people with Alzheimer's disease? Health Qual Life Outcomes. 2017 Jan 21;15(1):16. 

Reed C, Happich M, Argimon JM, Haro JM, Wimo A, Bruno G, Dodel R, Jones RW, Vellas B, Belger M.
What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study. J Alzheimers Dis. 2017;57(3):797-812.

van der Wardt V, Harrison JK, Welsh T, Conroy S, Gladman J.
Withdrawal of antihypertensive medication: a systematic review. J Hypertens. 2017 May 9. [Epub ahead of print]

2016 - Original Papers

Belger M, Haro JM, Reed C, Happich M, Kahle-Wrobleski K, Argimon JM, Bruno G, Dodel R, Jones RW, Vellas B & Wimo A.
How to deal with missing longitudinal data in cost of illness analysis in Alzheimer's disease-suggestions from the GERAS observational study. BMC Med Res Methodol. 2016; 16(1), 83.

Cummings J, Aisen PS, DuBois B, Frolich L, Jack CR, Jones RW, Morris JC, Raskin J, Dowsett SA & Scheltens P.
Drug development in Alzheimer's disease: the path to 2025. Alzheimers Res Ther, 2016: 8: 39.rn

Ozer S, Noonan K, Burke M, Young J, Barber S, Forster A, Jones R.
The validity of the Memory Alteration Test and the Test Your Memory test for community-based identification of amnestic mild cognitive impairment. Alzheimers Dement. 2016 May 2.  [Epub ahead of print]

Reed C, Belger M, Vellas B, Andrews JS, Argimon JM, Bruno G, Jones RW, Wimo A & Haro JM.
Identifying factors of activities of daily living important for cost and caregiver outcomes in Alzheimer's disease. Int Psychogeriatr. 2016;28(2):247-59.

2015 - Original Papers

Bocchetta M, Galluzzi S, Kehoe PG, Aguera E, Bernabei R, Bullock R, Ceccaldi M, Dartigues JF, de Mendonu00e7a A, Didic M, Eriksdotter M, Fu00e9lician O, Fru00f6lich L, Gertz HJ, Hallikainen M, Hasselbalch SG, Hausner L, Heuser I, Jessen F, Jones RW, Kurz A, Lawlor B, Lleo A, Martinez-Lage P, Mecocci P, Mehrabian S, Monsch A, Nobili F, Nordberg A, Rikkert MO, Orgogozo JM, Pasquier F, Peters O, Salmon E, Su00e1nchez-Castellano C, Santana I, Sarazin M, Traykov L, Tsolaki M, Visser PJ, Wallin u00c5K, Wilcock G, Wilkinson D, Wolf H, Yener G, Zekry D, Frisoni GB.
The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey. Alzheimers Dement. 2015 Feb;11(2):195-206.e1. doi: 10.1016/j.jalz.2014.06.006. Epub 2014 Aug 20.

Chouliaras L, Kenis G, Visser PJ, Scheltens P, Tsolaki M, Jones RW, et al.
DNMT3A moderates cognitive decline in subjects with mild cognitive impairment: replicated evidence from two mild cognitive impairment cohorts. Epigenomics. 2015;7(4):533-7.


Coley N, Gallini A, Gares V, Gardette V, Andrieu S. (Jones RW collaborator)
A Longitudinal Study of Transitions Between Informal and Formal Care in Alzheimer Disease Using Multistate Models in the European ICTUS Cohort. J Am Med Dir Assoc. 2015;16(12):1104.e1-7.

Dodel R, Belger M, Reed C, Wimo A, Jones RW, Happich M, Argimon JM, Bruno G, Vellas B, Haro JM.
Determinants of societal costs in Alzheimer's disease: GERAS study baseline results. Alzheimers Dement. 2015 Apr 4. pii: S1552-5260(15)00082-5. doi: 10.1016/j.jalz.2015.02.005. [Epub ahead of print]


Hoffman P, Clarke N, Jones RW, Noonan KA.
Vocabulary relearning in semantic dementia: Positive and negative consequences of increasing variability in the learning experience. Neuropsychologia. 2015 Jan 10. [Epub ahead of print]


Jones RW, Romeo R, Trigg R, Knapp M, Sato A, King D, Niecko T, Lacey L. (DADE Investigator Group).
Dependence in Alzheimer's disease and service use costs,quality of life, and caregiver burden: The DADE study. Alzheimers Dement. 2015 Mar;11(3):280-90. doi: 10.1016/j.jalz.2014.03.001. Epub 2014 Jul 26.

Reed C, Barrett A, Lebrec J, Dodel R, Jones RW, Vellas B, et al.
How Useful are Eq-5d And Zbi In Assessing The Impact of Caring for Alzheimer's Disease Patients? Value Health. 2015;18(7):A760.

Trigg R, Jones RW, Knapp M, King D, Lacey LA; DADE-2 Investigator Groups.
The relationship between changes in quality of life outcomes and progression of Alzheimer's disease: results from the dependence in AD in England 2 longitudinal study. Int J Geriatr Psychiatry. 2015 Apr;30(4):400-8. doi: 10.1002/gps.4150. Epub 2014 Jun 12.

Wessels AM, Siemers ER, Yu P, Andersen SW, Holdridge KC, Sims JR, Sundell K, Stern Y, Rentz DM, Dubois B, Jones RW, Cummings J, Aisen PS.
A Combined Measure of Cognition and Function for Clinical Trials: The Integrated Alzheimer's Disease Rating Scale (iADRS). J Prev Alzheimers Dis. 2015;2(4):227-41.


2014 - Original Papers


Canevelli, M., Adali, N., Kelaiditi, E., Cantet, C., Ousset, P-J., Cesari, M. Ictus DSA Group [Jones RW member of Ictus study group]
Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: Data from the ICTUS study. Phytomedicine 2014; 21(6): 888-92.


Clare, L., Nelis, S.M., Quinn, C., Martyr, A., Henderson, C., Hindle, J.V., Jones, I.R., Jones, R.W., Knapp, M., Kopelman, M.D., Morris, R.G., Pickett, J.A., Rusted, J.M., Savitch, N.M., Thom, J.M. & Victor, C.R.
Improving the experience of dementia and enhancing active life - living well with dementia: study protocol for the IDEAL study. Health Qual Life Outcomes. 2014; 12(1):164.


Clarke, N. & Jones, R.W. 
25 years and counting. The Journal of Dementia Care 2014; 22(3): 14-15.


Gardette, V., Lapeyre-Mestre, M., Piau, A., Gallini, A., Cantet, C., Montastruc, J.L., Vellas, B., Andrieu, S. & Ictus Group. [Jones RW member of Ictus study group]
A 2-year prospective cohort study of antidementia drug non-persistency in mild-to-moderate Alzheimer's disease in Europe : predictors of discontinuation and switch in the ICTUS study. CNS Drugs 2014; 28(2):157-70.


Haro, J.M., Kahle-Wrobleski, K., Bruno, G., Belger, M., Dell'Agnello, G., Dodel, R., Jones, R.W., Reed, C.C., Vellas, B., Wimo, A. & Argimon, J.M.
Analysis of burden in caregivers of people with Alzheimer's disease using self-report and supervision hours. J Nutr Health Aging 2014; 18(7): 677-84.


Reed,C., Belger, M., Dell'Agnello,G., Wimo, A., Argimon,J.M. Bruno,G., Dodel,R., Haro,J.M., Jones,R.W. & Vellas,B.  
Caregiver Burden in Alzheimer's Disease: Differential Associations in Adult-Child and Spousal Caregivers in the GERAS Observational Study. Dementia and Geriatric Cognitive Disorders Extra 2014; (4): 51-64.


Ritchie, C.W., Bajwa, J., Coleman, G., Hope, K., Jones, R.W., Lawton, M., Marven, M. & Passmore, P.
Souvenaid: a new approach to management of early Alzheimer's disease. The Journal of Nutrition, Health & Aging 2014; 18(3): 291-9.


Wimo, A., Ballard, C., Brayne, C., Gauthier, S., Handels, R., Jones, R.W., Jonsson, L., Khachaturian, A.S. & Kramberger, M.
Health economic evaluation of treatments for Alzheimer's disease: impact of new diagnostic criteria. Journal of Internal Medicine 2014; 275(3):304-16.




2014 - Book Chapters


Jones, R.W.
Preventing Alzheimer's Disease. In: Bairu, M. Weiner, M. W. eds. Global Clinical Trials for Alzheimer's Disease: Design, Implementation, and Standardization.  Elsevier Academic Press.  2014. pp 33-46.



2013 - Original Papers


Canevelli, M., Adali, N., Cantet, C., Andrieu, S., Bruno, G., Cesari, M., Vellas, B. & Ictus Dsa Grp [Jones RW member of Ictus study group]
Impact of behavioral subsyndromes on cognitive decline in Alzheimer's disease: data from the ICTUS study. Journal of Neurolog 2013; 260 (7):1859-1865.


Clare, L., Bayer, A., Burns, A., Corbett, A., Jones, R., Knapp, M., Kopelman, M., Kudlicka, A., Leroi, I., Oyebode, J., Pool, J., Woods, B. & Whitaker, R.
Goal-oriented cognitive rehabilitation in early-stage dementia: study protocol for a multi-centre single-blind randomised controlled trial (GREAT).Trials;14: 152.


Damian, M., Hausner, L., Jekel, K., Richter, M., Froelich, L., Almkvist, O., Boada, M., Bullock, R., De Deyn, P.P., Frisoni, G.B., Hampel, H., Jones, R.W., Kehoe, P., Lenoir, H., Minthon, L., Olde Rikkert, M.G., Rodriguez, G., Scheltens, P., Soininen, H., Spiru, L., Touchon, J., Tsolaki, M., Vellas, B., Verhey, F.R., Winblad, B., Wahlund, L.O., Wilcock, G. & Visser, P.J.
Single-Domain Amnestic Mild Cognitive Impairment Identified by Cluster Analysis Predicts Alzheimer's Disease in the European Prospective DESCRIPA Study. Dement Geriatr Cogn Disord, 2013; 36: 1-19.


Hoffman, P., Jones, R.W. & Lambon Ralph, M.A.
Be concrete to be comprehended: Consistent imageability effects in semantic dementia for nouns, verbs, synonyms and associates. Cortex 2013; 49: 1206-18.


Martinez, C., Jones, R.W. & Rietbrock, S.
Trends in the prevalence of antipsychotic drug use among patients with Alzheimer's disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study. BMJ Open; 2013: 3.

Noonan, K.A., Jefferies, E., Garrard, P., Eshan, S. & Lambon Ralph, M.A.
Demonstrating the qualitative differences between semantic aphasia and semantic dementia: a novel exploration of nonverbal semantic processing. Behav Neurol. 2013; 26: 7-20.


Noonan, K.A., Jefferies, E., Visser, M. & Lambon Ralph, M.A., 2013.
Going beyond Inferior Prefrontal Involvement in Semantic Control: Evidence for the Additional Contribution of Dorsal Angular Gyrus and Posterior Middle Temporal Cortex. Journal of cognitive neuroscience, 25(11), pp. 1824-50.


Vermeiren, A.P., Bosma, H., Visser, P.J., Zeegers, M.P., Graff, C., Ewers, M., Frisoni, G.B., Fru00f6lich, L., Hampel, H., Jones, R.W., Kehoe, P.G., Lenoir, H., Minthon, L., Nobili, F.M., Olde Rikkert, M., Rigaud, A.S., Scheltens, P., Soininen, H., Spiru, L., Tsolaki, M., Wahlund, L.O., Vellas, B., Wilcock, G., Elias-Sonnenschein, L.S. & Verhey, F.R.
The Association Between APOE u03b54 and Alzheimer-type Dementia Among Memory Clinic Patients is Confined to those with a Higher Education. The DESCRIPA Study. J Alzheimers Dis  2013; 35: 241-246


Wimo, A., Reed, C.C., Dodel, R., Belger, M., Jones, R.W., Happich, M., Argimon, J.M., Bruno, G., Novick, D., Vellas, B. & Haro, J.M.
The GERAS Study: A Prospective Observational Study of Costs and Resource Use in Community Dwellers with Alzheimer's Disease in Three European Countries - Study Design and Baseline Findings. J Alzheimers Dis. 2013; 36(2): 285-399.



2013 - Book Chapters


Jones, R.W.
Pharmacological treatment of dementia. In: Dening,T. & Thomas, A. eds. Textbook of Old Age Psychiatry 2nd  Edition. Oxford: Oxford University Press. 2013: Chapter 38, 503-512.


Jones, R.W.
Services for people with mild dementia. In: H. de Waal, C. Lyketsos, D. Ames & J. O'Brien, eds. Designing and Delivering Dementia Services. Wiley-Blackwell 2013; Section 2.5 Service models p 60-72.


The Research Institute for the Care of Older People


The RICE Centre

Royal United Hospital

Combe Park

Bath, BA1 3NG

Contact Us

Tel: 01225 476 420

Fax: 01225 463 403


Find us Map

Website Info

Terms & Conditions


Site Map


Join us on twitter